Hsp90 Recognizes a Common Surface on Client Kinases*

Hsp90 is a highly abundant chaperone whose clientele includes hundreds of cellular proteins, many of which are central players in key signal transduction pathways and the majority of which are protein kinases. In light of the variety of Hsp90 clientele, the mechanism of selectivity of the chaperone toward its client proteins is a major open question. Focusing on human kinases, we have demonstrated that the chaperone recognizes a common surface in the amino-terminal lobe of kinases from diverse families, including two newly identified clients, NFκB-inducing kinase and death-associated protein kinase, and the oncoprotein HER2/ErbB-2. Surface electrostatics determine the interaction with the Hsp90 chaperone complex such that introduction of a negative charge within this region disrupts recognition. Compiling information on the Hsp90 dependence of 105 protein kinases, including 16 kinases whose relationship to Hsp90 is first examined in this study, reveals that surface features, rather than a contiguous amino acid sequence, define the capacity of the Hsp90 chaperone machine to recognize client kinases. Analyzing Hsp90 regulation of two major signaling cascades, the mitogen-activated protein kinase and phosphatidylinositol 3-kinase, leads us to propose that the selectivity of the chaperone to specific kinases is functional, namely that Hsp90 controls kinases that function as hubs integrating multiple inputs. These lessons bear significance to pharmacological attempts to target the chaperone in human pathologies, such as cancer.

[1]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[2]  R. Matts,et al.  Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation. , 2005, Experimental cell research.

[3]  L. Pearl,et al.  A Two-Hybrid Screen of the Yeast Proteome for Hsp90 Interactors Uncovers a Novel Hsp90 Chaperone Requirement in the Activity of a Stress-Activated Mitogen-Activated Protein Kinase, Slt2p (Mpk1p) , 2005, Eukaryotic Cell.

[4]  Andrew Emili,et al.  Navigating the Chaperone Network: An Integrative Map of Physical and Genetic Interactions Mediated by the Hsp90 Chaperone , 2005, Cell.

[5]  J. Minna,et al.  Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. , 2005, Cancer research.

[6]  Zhexin Xiang,et al.  Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex , 2005, Nature Structural &Molecular Biology.

[7]  Yosef Yarden,et al.  Hsp90 restrains ErbB‐2/HER2 signalling by limiting heterodimer formation , 2004, EMBO reports.

[8]  R. Matts,et al.  Definition of Protein Kinase Sequence Motifs That Trigger High Affinity Binding of Hsp90 and Cdc37* , 2004, Journal of Biological Chemistry.

[9]  Hong Zhang,et al.  Targeting multiple signal transduction pathways through inhibition of Hsp90 , 2004, Journal of Molecular Medicine.

[10]  Wei Wu,et al.  Hsp90/p50cdc37 Is Required for Mixed-lineage Kinase (MLK) 3 Signaling* , 2004, Journal of Biological Chemistry.

[11]  Giulio Superti-Furga,et al.  A physical and functional map of the human TNF-α/NF-κB signal transduction pathway , 2004, Nature Cell Biology.

[12]  Joyce Cheung-Flynn,et al.  Functional Specificity of Co-Chaperone Interactions with Hsp90 Client Proteins , 2004, Critical reviews in biochemistry and molecular biology.

[13]  Yosef Yarden,et al.  The Achilles Heel of ErbB-2/HER2: Regulation by the Hsp90 Chaperone Machine and Potential for Pharmacological Intervention , 2004, Cell cycle.

[14]  M. Rossel,et al.  Stability of the Peutz–Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37 , 2003, Oncogene.

[15]  D. Morrison,et al.  Regulation of MAP kinase signaling modules by scaffold proteins in mammals. , 2003, Annual review of cell and developmental biology.

[16]  S. Uma,et al.  High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients. , 2003, Biochemistry.

[17]  L. Neckers,et al.  Heat shock protein 90 , 2003, Current opinion in oncology.

[18]  R. Matts,et al.  Phosphorylation of Serine 13 Is Required for the Proper Function of the Hsp90 Co-chaperone, Cdc37* , 2003, Journal of Biological Chemistry.

[19]  W. Pratt,et al.  Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery 1 , 2003, Experimental biology and medicine.

[20]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[21]  M. Sliwkowski,et al.  Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor* , 2002, The Journal of Biological Chemistry.

[22]  N. Rosen,et al.  Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 Function* , 2002, The Journal of Biological Chemistry.

[23]  S. Kaul,et al.  Mutations at Positions 547–553 of Rat Glucocorticoid Receptors Reveal That hsp90 Binding Requires the Presence, but Not Defined Composition, of a Seven-amino Acid Sequence at the Amino Terminus of the Ligand Binding Domain* , 2002, The Journal of Biological Chemistry.

[24]  R. Morimoto,et al.  Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. , 2002, Journal of cell science.

[25]  H. Berman,et al.  The Protein Data Bank. , 2002, Acta crystallographica. Section D, Biological crystallography.

[26]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[27]  A. Citri,et al.  Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy , 2002, The EMBO journal.

[28]  J. Kuriyan,et al.  The Conformational Plasticity of Protein Kinases , 2002, Cell.

[29]  A. Ishida,et al.  Involvement of Hsp90 in Signaling and Stability of 3-Phosphoinositide-dependent Kinase-1* , 2002, The Journal of Biological Chemistry.

[30]  J. Albrecht,et al.  C/EBPα triggers proteasome‐dependent degradation of cdk4 during growth arrest , 2002 .

[31]  J. Buchner,et al.  Hsp90: Chaperoning signal transduction , 2001, Journal of cellular physiology.

[32]  O. Donzé,et al.  The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA‐dependent kinase PKR , 2001, The EMBO journal.

[33]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[34]  Y. Yarden,et al.  Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp90* , 2001, The Journal of Biological Chemistry.

[35]  H. Osada,et al.  Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines , 2000, Nature Cell Biology.

[36]  G. Carpenter,et al.  Geldanamycin Induces ErbB-2 Degradation by Proteolytic Fragmentation* , 2000, The Journal of Biological Chemistry.

[37]  L. Neckers,et al.  The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[38]  M. Marsh,et al.  Hsp90 is essential for the synthesis and subsequent membrane association, but not the maintenance, of the Src-kinase p56(lck). , 2000, Molecular biology of the cell.

[39]  N. Rosen,et al.  Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases. , 2000, Cancer research.

[40]  G. Giannoukos,et al.  The Seven Amino Acids (547–553) of Rat Glucocorticoid Receptor Required for Steroid and Hsp90 Binding Contain a Functionally Independent LXXLL Motif That Is Critical for Steroid Binding* , 1999, The Journal of Biological Chemistry.

[41]  S. Matsuda,et al.  Temperature-sensitive ZAP70 Mutants Degrading through a Proteasome-independent Pathway , 1999, The Journal of Biological Chemistry.

[42]  G. Giannoukos,et al.  Binding of hsp90 to the Glucocorticoid Receptor Requires a Specific 7-Amino Acid Sequence at the Amino Terminus of the Hormone-binding Domain* , 1998, The Journal of Biological Chemistry.

[43]  T. Imamura,et al.  Involvement of Heat Shock Protein 90 in the Degradation of Mutant Insulin Receptors by the Proteasome* , 1998, The Journal of Biological Chemistry.

[44]  Smith Df Sequence motifs shared between chaperone components participating in the assembly of progesterone receptor complexes. , 1998 .

[45]  L. Neckers,et al.  Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway , 1996, Molecular and cellular biology.

[46]  S. Pietrokovski Searching databases of conserved sequence regions by aligning protein multiple-alignments. , 1996, Nucleic acids research.

[47]  J. Harper,et al.  Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. , 1996, Genes & development.

[48]  S. Henikoff,et al.  Automated construction and graphical presentation of protein blocks from unaligned sequences. , 1995, Gene.

[49]  R. Matts,et al.  Association of Hsp90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function. , 1994, Biochemistry.

[50]  B. Honig,et al.  Calculation of electrostatic potentials in an enzyme active site , 1987, Nature.

[51]  J. Bishop,et al.  Transit of pp60v-src to the plasma membrane. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Carpenter,et al.  Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation. , 2003, Cancer research.